Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed
Crossref DOI link: https://doi.org/10.1007/s40120-016-0056-2
Published Online: 2016-11-22
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lacey, Loretto
Bobula, Joel
Niecko, Timothy
Leibman, Christopher
Funding for this research was provided by:
Pfizer
Janssen Pharmaceuticals